SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DRS - Draft Registration Statement:
SEC Accession No. 0001104659-21-042551
Filing Date
2021-03-26
Accepted
2021-03-26 17:06:21
Documents
52

Document Format Files

Seq Description Document Type Size
1 filename1.htm DRS 3142559
2 filename2.htm EX-3.1 183727
3 filename3.htm EX-3.3 91149
4 filename4.htm EX-4.2 331778
5 filename5.htm EX-4.3 145307
6 filename6.htm EX-10.1 83760
7 filename7.htm EX-10.2 108915
8 filename8.htm EX-10.3 3874
9 filename9.htm EX-10.4 4175
10 filename10.htm EX-10.5 4198
11 filename11.htm EX-10.6 3940
12 filename12.htm EX-10.7 3965
13 filename13.htm EX-10.10 43183
14 filename14.htm EX-10.11 52143
15 filename15.htm EX-10.12 56575
16 filename16.htm EX-10.23 485024
17 filename17.htm EX-10.29 22843
18 filename18.htm EX-10.30 22609
19 filename19.htm EX-21.1 3125
20 GRAPHIC lg_centurytherap-4clr.jpg GRAPHIC 36305
21 GRAPHIC tm218551d1-bc_addition4clr.jpg GRAPHIC 112620
22 GRAPHIC tm218551d1-bc_cartcells4clr.jpg GRAPHIC 44042
23 GRAPHIC tm218551d1-bc_safety4clr.jpg GRAPHIC 66517
24 GRAPHIC tm218551d1-bc_transgen4c.jpg GRAPHIC 109012
25 GRAPHIC tm218551d1-fc_evolution4clr.jpg GRAPHIC 65253
26 GRAPHIC tm218551d1-fc_pipeline4clr.jpg GRAPHIC 43936
27 GRAPHIC tm218551d1-lc_differentbwlr.jpg GRAPHIC 77294
28 GRAPHIC tm218551d1-lc_elimi4clr.jpg GRAPHIC 106290
29 GRAPHIC tm218551d1-lc_eliminat4c.jpg GRAPHIC 154726
30 GRAPHIC tm218551d1-lc_express4clr.jpg GRAPHIC 101371
31 GRAPHIC tm218551d1-lc_illustrat4clr.jpg GRAPHIC 133581
32 GRAPHIC tm218551d1-lc_killcd194clr.jpg GRAPHIC 61590
33 GRAPHIC tm218551d1-lc_oucarink4c.jpg GRAPHIC 73945
34 GRAPHIC tm218551d1-lc_ourinkcells4c.jpg GRAPHIC 70065
35 GRAPHIC tm218551d1-lc_robust4clr.jpg GRAPHIC 208282
36 GRAPHIC tm218551d1-lc_serial4clr.jpg GRAPHIC 177602
37 GRAPHIC tm218551d1-lc_targetcel4clr.jpg GRAPHIC 64818
38 GRAPHIC tm218551d1-lc_tipscbwlr.jpg GRAPHIC 63672
39 GRAPHIC tm218551d1-lc_tumor4clr.jpg GRAPHIC 43821
40 GRAPHIC tm218551d1-lc_tumorgrow4clr.jpg GRAPHIC 130255
41 GRAPHIC tm218551d1-org_effect4clr.jpg GRAPHIC 127140
42 GRAPHIC tm218551d1-org_leaddisc4clr.jpg GRAPHIC 153630
43 GRAPHIC tm218551d1-ph_camelid4clr.jpg GRAPHIC 102189
44 GRAPHIC tm218551d1-ph_carconst4clr.jpg GRAPHIC 96921
45 GRAPHIC tm218551d1-ph_cd133targ4clr.jpg GRAPHIC 145817
46 GRAPHIC tm218551d1-ph_corechar4clr.jpg GRAPHIC 114909
47 GRAPHIC tm218551d1-ph_develop4clr.jpg GRAPHIC 118992
48 GRAPHIC tm218551d1-ph_engineer4clr.jpg GRAPHIC 106814
49 GRAPHIC tm218551d1-ph_future4clr.jpg GRAPHIC 65582
50 GRAPHIC tm218551d1-ph_ouruse4clr.jpg GRAPHIC 126820
51 GRAPHIC tm218551d1-ph_phenotypebwlr.jpg GRAPHIC 113063
52 GRAPHIC tm218551d1-ph_single4clr.jpg GRAPHIC 107605
  Complete submission text file 0001104659-21-042551.txt   9356666
Mailing Address 3675 MARKET STREET PHILADELPHIA PA 19104
Business Address 3675 MARKET STREET PHILADELPHIA PA 19104 215-981-4000
Century Therapeutics, Inc. (Filer) CIK: 0001850119 (see all company filings)

IRS No.: 842040295 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DRS | Act: 33 | File No.: 377-04523 | Film No.: 21778367
SIC: 2836 Biological Products, (No Diagnostic Substances)